Saving Seafood

Federal judge rules FDA must reevaluate effects of potential GE salmon escape

November 9, 2020 — AquaBounty Technologies is facing another legal battle over its AquAdvantage salmon, as a California court ruled last week that the Food and Drug Administration (FDA) violated core environmental laws in approving genetically engineered salmon for sale and consumption.

On 5 November, a federal judge in San Francisco ruled the FDA ignored serious possible environmental consequences by approving genetically engineered salmon, and was also violating the National Environmental Policy Act. The judge also ruled the FDA approval was in violation of the Endangered Species Act, as the agency did not consult with the National Marine Fisheries Service and the Fish and Wildlife Service before taking an action that “may affect” a listed or endangered species.

Read the full story at Seafood Source

FDA must develop plan to label genetically engineered salmon, Congress says

December 17, 2015 — The sprawling federal spending bill unveiled this week on Capitol Hill included a small passage with potentially big implications in the food world.

In two paragraphs on page 106, lawmakers instructed the Food and Drug Administration to forbid the sale of genetically engineered salmon until the agency puts in place labeling guidelines and “a program to disclose to consumers” whether a fish has been genetically altered. The language comes just a month after FDA made salmon the first genetically modified animal approved for human consumption and represents a victory for advocates who have long opposed such foods from reaching Americans’ dinner plates. At the very least, they say, consumers ought to know what they are buying.

The fish in the spotlight is the AquAdvantage salmon, produced by Massachusetts-based AquaBounty. The Atlantic salmon contains a growth hormone from a Chinook salmon and a gene from the ocean pout — a combination to help it grow large enough for consumption in 18 months instead of the typical three years.

Read the full story at The Washington Post

 

Are You Eating Frankenfish?

December 15, 2015 — This month, Congress may decide whether consumers are smart enough to be trusted with their own food choices. Some lawmakers are trying to insert language into must-pass spending legislation that would block states from giving consumers the right to know whether their food contains genetically modified ingredients.

They must be stopped.

Nine out of 10 Americans want G.M.O. disclosure on food packages, according to a 2013 New York Times poll, just like consumers in 64 other nations. But powerful members of the agriculture and appropriations committees, along with their allies in agribusiness corporations like Monsanto, want to keep consumers in the dark. That’s why opponents of this effort have called it the DARK Act — or the Deny Americans the Right to Know Act.

As a chef, I’m proud of the food I serve. The idea that I would try to hide what’s in my food from my customers offends everything I believe in. It’s also really bad for business.

Why, then, have companies like Kellogg and groups like the Grocery Manufacturers Association spent millions in recent years to lobby against transparency? They say, in effect: “Trust us, folks. We looked into it. G.M.O. ingredients are safe.” But what they’re missing is that consumers want to make their own judgments. Consumers are saying: “Trust me. Let me do my own homework and make my own choices.”

Read the full opinion piece at the New York Times

GMO fish and the strangeness of American salmon

December 2, 2015 — Sometime in the next few years, an entirely new fish will appear on American plates. After several decades of biotech research and a final upstream push past the U.S. Food and Drug Administration last month, the AquaBounty AquAdvantage salmon, a genetically engineered species of fish, will go into commercial production. While modified plants like corn and soy abound in the American diet, this will mark the first time in history that an engineered animal has been approved for human consumption. The new fish’s genetic code is comprised of components from three fish: base DNA from an Atlantic salmon; a growth gene from a Pacific Chinook salmon; and a promoter, a kind of “on” switch for genes, from a knobby-headed eel-shaped creature called an ocean pout.

The salmon’s pathway to the market will involve a similarly complex formulation. The first phase of AquAdvantage production will take place in Canada, on Prince Edward Island. There, the all-female eggs will be rendered sterile through a pressure treatment. They will then be flown to Panama, where they’ll be hatched, raised to harvestable size, slaughtered, and imported into the U.S. as the familiar orange-hued fillets that Americans have come to prefer above all other types of fish. Though AquaBounty hopes that the costs of this circuitous route to market could be offset by the savings incurred from the fish’s rapid growth (the company claims that AquAdvantage reaches maturity in about half the time as unmodified fish), the company is hoping to eventually gain permission to farm the fish here at home. “In the longer run,” AquaBounty’s co-founder, Elliot Entis, wrote me in an e-mail, “the real payoff will be when inland recirculating facilities are built in the U.S.”

Read the full story at The New Yorker

FDA OK’s genetically modified salmon

November 20, 2015 — For the first time, Americans will be able to dine on a genetically altered animal, after federal regulators on Thursday approved a Massachusetts biotechnology company’s bid to modify salmon for human consumption.

After years of testing the company’s modified fish, regulators said there are no “biologically relevant differences” between the so-called AquAdvantage salmon and other farm-raised Atlantic salmon. Still, for the time being the FDA has barred the fish from being cultivated in the United States and has issued strict regulations to prevent the modified salmon from breeding with those in the wild.

The decision was a big win for AquaBounty, which began seeking approval in the 1990s for its technique of inserting growth hormone genes from Chinook salmon and an eel-like creature called ocean pout into the DNA of Atlantic salmon. The faster the fish grow, the more the company can produce and sell, potentially reducing overfishing of the oceans and developing a new source of food for a growing global population.

Company officials said the federal approval would create a new industry in the United States, which they say imports 95 percent of its Atlantic salmon. But it was unclear how long it might take before the fish appear in supermarkets.

“AquAdvantage salmon is a game-changer that brings healthy and nutritious food to consumers in an environmentally responsible manner, without damaging the ocean and other marine habitats,” Ronald L. Stotish, the chief executive of AquaBounty, said in a statement.

Read the full story at the Boston Globe